Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEIA: Lisdexamfetamine in Adolescents and Young Adults With ADHD
NCT02170298Phase 4Terminated
- Sponsor
- University of California, Davis
- Start
- Feb 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lisdexamfetamine in attention deficit hyperactivity disorder (ADHD), sponsored by University of California, Davis. Started Feb 2014; status: terminated.
02
Drugs
lisdexamfetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02170298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02170298.